HomeCOO • NASDAQ
add
Cooper Companies Inc
Previous close
$105.73
Day range
$104.50 - $106.95
Year range
$75.94 - $106.95
Market cap
21.05B USD
Avg Volume
1.04M
P/E ratio
58.88
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jul 2024info | Y/Y change |
---|---|---|
Revenue | 1.00B | 7.80% |
Operating expense | 470.50M | 2.64% |
Net income | 104.70M | 22.74% |
Net profit margin | 10.44 | 13.85% |
Earnings per share | 0.96 | 14.63% |
EBITDA | 295.50M | 20.07% |
Effective tax rate | 36.04% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jul 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 109.70M | -6.48% |
Total assets | 12.11B | 3.51% |
Total liabilities | 4.18B | 0.34% |
Total equity | 7.93B | — |
Shares outstanding | 200.60M | — |
Price to book | 2.68 | — |
Return on assets | 4.08% | — |
Return on capital | 4.56% | — |
Cash Flow
Net change in cash
(USD) | Jul 2024info | Y/Y change |
---|---|---|
Net income | 104.70M | 22.74% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -2.80M | -151.85% |
Free cash flow | — | — |
About
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical, which manufactures medical devices and fertility and genomic products for the women's health care market. Wikipedia
Founded
1958
Headquarters
Website
Employees
15,000